UNC Hospitals is one of 378 facilities in the world, and among only 6 percent of all U.S. hospitals, that have earned Magnet designation.
Normal humans produce a novel, circular form of non-coding RNA that regulates aging
Resulting Database to Yield Big Gains for Genetic Scientists
Technology developed by UNC Lineberger members may lead to diagnostic test
Group Walks to Honor Emily Kleisch Crawford of Chapel Hill
An Interview With Oncology Clinical Pharmacist John Valgus, PharmD, BCOP, CPP
Interested in starting a regular exercise program and supporting a good cause?
It's a gene called DOT1L, and if you don't have enough of the DOT1L enzyme, you could be at risk for some types of heart disease.
UNC Lineberger members are involved in over 20 active startups.
The Henry family shares the story of brothers Collin and Patrick, both diagnosed with cancer and receiving care at the N.C. Cancer Hospital.
Anders was chosen for her work on breast cancer brain metastases. Hoadley was selected for her contributions to the analysis of glioblastomas.
The article discusses Bernard’s work with the UNC Palliative Care Program and the Supportive Care Consult Service and Clinic.
Richard Goldberg, MD is physician-in-chief of the N.C. Cancer Hospital and UNC Lineberger associate director of clinical research.
When the U.S. Food and Drug Administration (FDA) proposed new rules restricting outdoor tobacco advertising near schools and playgrounds in 2009, the tobacco industry argued that such rules would lead to a near complete ban on tobacco advertising in urban areas. An article in the March 2011 issue of the American Journal of Preventive Medicine shows that the effect of these rules would be less severe on businesses than the industry contends.
Sixty physicians at the University of North Carolina Hospitals are listed in the latest version of “America’s Top Doctors,” a compilation that is published annually by Castle Connolly Medical Ltd. Of those, 32 are members of UNC Lineberger Comprehensive Cancer Center or involved in UNC Cancer Care’s multidisciplinary programs.
UNC Lineberger member Kurt Ribisl, PhD, was part of the study's research team.
Weili Lin, PhD, has been appointed Director of the UNC Biomedical Research Imaging Center (BRIC).
James P. Evans, MD, PhD is lead author of a commentary about the potential of genomic medicine.
UNC Lineberger Physician Co-Author of Study of Screening Mammography in Women with Personal History of Breast Cancer
CHAPEL HILL, N.C. - A Triangle-based UNC spinoff company at the forefront of efforts to use nanotechnology to tackle diseases has received a $10 million investment from the Bill & Melinda Gates Foundation.
CHAPEL HILL, N.C. - Federico Innocenti, MD, PhD, has been appointed associate professor of pharmacy in the UNC Eshelman School of Pharmacy. He will serve as associate director of the UNC Institute for Pharmacogenomics and Individualized Therapy and a member of UNC Lineberger Comprehensive Cancer Center.
C.A.R.E. Behind the Chair® program scheduled for May9
CHAPEL HILL, N.C. - A UNC study released this week in the Journal of Clinical Oncology finds an increasing incidence of squamous cell carcinoma of the oral tongue in young white females in the United States over the last three decades.
CHAPEL HILL, N.C. - The article "Next Generation Treatment for Triple-Negative and Basal-Cell Breast Cancer" written by Jonathan Batchelor and published on the website cancernetwork.com on March 9, 2011 features an interview with UNC Lineberger member Lisa Carey, MD.
CHAPEL HILL, N.C. - My Colon Cancer Coach, a new website that launched this week, serves as a tool to help people diagnosed with colon cancer.
UNC researchers working toward a rehabilitation road map
CHAPEL HILL, N.C. - On Friday, March 11, a group of nurses gathered for a UNC Health Care Grand Rounds presentation by Jerome Schiro, RN, MN, OCN, Pat Decator, RN, BSN, OCN, and Amy De Pue, RN, BS, OCN.
Prestigious Breast Cancer Research Foundation-AACR Grant funds preclinical studies
Hearing of the House Energy and Commerce Committee's Subcommittee on Oversight and Investigations, July 20, 2010
"Tet is likely to be one of the important players for stem cell reprogramming."
New research from the University of North Carolina at Chapel Hill School of Medicine adds clarity to the connection. The study published on-line April 10th in the journal Nature Immunology finds that saturated fatty acids but not the unsaturated type can activate immune cells to produce an inflammatory protein, called interleukin-1beta.
UNC physician scientist receives National Academy of Sciences grant to develop cancer nanotechnology
Local show features UNC Lineberger
The UNC-Mission Hospital Cancer Partnership, part of the UNC Cancer Network, welcomes Candace Cox, RN, OCN, to the program staff.
Chapel Hill, NC - Samuel Cykert, MD, has received a $1.8 million five-year grant from the American Cancer Society (ACS) to study “Lung Cancer Surgery: Decisions Against Life Saving Care.”
CHAPEL HILL – Researchers at the University of North Carolina at Chapel Hill School of Medicine, after isolating normal stem cells that form the developing placenta, have given them the same properties of stem cells associated with an aggressive type of breast cancer.
NCCU-UNC Lineberger scientific collaboration yields new findings
Prestigious Executive Leadership in Academic Medicine Program builds pipeline of women leaders
UNC Lineberger Comprehensive Cancer Center a Beneficiary
A study of DNA rearrangements in roundworm chromosomes may offer new insight into large-scale genome duplications that occur in developing tumors.
The 35th annual UNC Lineberger scientific symposium attracted more than 530 participants. Held at the Friday Center on April 27-28, 2011, the event featured speakers on "Cell Metabolism and Cancer."
CHAPEL HILL, N.C. – Dr. Carolyn Sartor discussed the “New Life After Cancer” organization on the April 28, 2011 broadcast of Here's to Your Health. Dr. Sartor is a breast cancer survivor and former Chair of Radiation Oncology at UNC.
Richard Goldberg, MD, distinguished professor and chief of the division of hematology/oncology, has been appointed to chair the 2012 Gastrointestinal Cancers Symposium Steering Committee on behalf of the American Society for Clinical Oncology (ASCO).
Innovative collaboration between physics and cell biology demonstrates pathway
A University of North Carolina at Chapel Hill study has joined the ranks of an elite group of programs recognized for their contributions to reducing cancer.
Chapel Hill - When cancer patients experience medical problems, they may visit emergency departments, but how often and for what reasons, there is little data.